GNZ-BRC is the first custom panel breast cancer genetic screening test in Turkey, approved by Ministry of Health and registered to the UTS (Product Tracking System).

GNZ-BRC differs from standard screening tests with its AI software and custom panel including hotspot regions in 5 genes (ATM, FGFR2, MAP3K, BRCA1, BRCA2). It is faster, more accurate, more affordable and easier to use.

Using a saliva sample, GNZ-BRC provides more information than standard genetic screening tests, including potential risks for early stage patients and personalized advice for prevention.